Zobrazeno 1 - 10
of 509
pro vyhledávání: '"Dario Giugliano"'
Autor:
Dario Giugliano, Miriam Longo, Simona Signoriello, Maria Ida Maiorino, Bruno Solerte, Paolo Chiodini, Katherine Esposito
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium glucose co-transporter-2 (SGLT-2) inhibitors reduce cardiorenal outcomes. We performed a network meta-analysis to compare the effect on cardiorenal outcomes among GLP-
Externí odkaz:
https://doaj.org/article/8829922a92d644008b5b6863c5d8ab36
Autor:
Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)
Abstract Background It has been suggested that sodium–glucose cotransporter 2 (SGLT-2) inhibitors reduce the cardiorenal risk in patients with type 2 diabetes (T2D). The purpose of this study is to provide an update of all large cardiovascular outc
Externí odkaz:
https://doaj.org/article/3c366d570ad24c4d8a1bcf39be258452
Autor:
Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo, Giuseppe Bellastella, Katherine Esposito
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-5 (2021)
Abstract Cardiovascular disease (CVD) remains the leading cause of death in patients with type 2 diabetes (T2D). Older age, prior heart failure (HF) and CV events, peripheral artery disease, and kidney complications can identify a subgroup of patient
Externí odkaz:
https://doaj.org/article/a251e070cf0e4baf80ee66f12731b997
Autor:
Maria Ida Maiorino, Miriam Longo, Lorenzo Scappaticcio, Giuseppe Bellastella, Paolo Chiodini, Katherine Esposito, Dario Giugliano
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-10 (2021)
Abstract Background Besides providing reassurance about cardiovascular (CV) safety of newer diabetes drugs, cardiovascular outcome trials (CVOTs) have also shown encouraging benefits on some CV endpoints. The contribution of the better glycemic contr
Externí odkaz:
https://doaj.org/article/9aedeaf813a14594b1a2323b1bd72ef0
Autor:
Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo, Paola Caruso, Maria Ida Maiorino, Giuseppe Bellastella, Antonio Ceriello, Paolo Chiodini, Katherine Esposito
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)
Abstract Background A meta-analysis is presented of cardiovascular outcome trials (CVOTs) comparing glucagon-like peptide-1 receptor agonists (GLP-1RA) versus placebo on cardiorenal outcomes in patients with type 2 diabetes mellitus (T2DM). Methods W
Externí odkaz:
https://doaj.org/article/350ec22390e74c53b7c53d0cd7a32144
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-4 (2021)
Abstract Lower extremity amputations (LEA) are associated with a high mortality and medical expenditure. Diabetes accounts for 45% to 70% of LEA and is one of the most potent risk factors for peripheral artery diseases (PAD). The existence of a link
Externí odkaz:
https://doaj.org/article/720972c5d9054ad3b47795a5e3ba59ad
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-4 (2021)
Abstract In this commentary, we introduce the concepts of removed and residual risks in conditioning thecardiorenal outlook of patients with type 2 diabetes (T2D). The removed cardiorenal risk represents the risk of progression of CV events (major ad
Externí odkaz:
https://doaj.org/article/f6c5bd9f4d4b477bba573c0b6b0cb286
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-10 (2021)
Abstract Hospitalization for major diabetes complications, including myocardial infarction, stroke, lower-extremity amputation, and end-stage kidney disease, is on the rise and represents a great health burden for patients with type 2 diabetes (T2D),
Externí odkaz:
https://doaj.org/article/14dcd469df9b4a2399ac892cc8637ce4
Autor:
Katherine Esposito, Maria Ida Maiorino, Giuseppe Bellastella, Dario Giugliano, Francesco Saverio Mennini, Marco Trabucco Aurilio, Lorenzo Scappaticcio, Miriam Longo, Claudia Nardone, Luca Coppeta, Simone Gazzillo, Raffaele Migliorini
Publikováno v:
BMJ Open, Vol 12, Iss 5 (2022)
Objectives The aim of this study is to estimate the average number of claims for social security benefits from workers with diabetes-related disability.Design Nationwide retrospective cohort study.Setting The database of the Italian Social Security I
Externí odkaz:
https://doaj.org/article/b5cc7e065a8a44f98bb9a1c63895e413
Autor:
Miriam Longo, Paola Caruso, Maria Ida Maiorino, Giuseppe Bellastella, Dario Giugliano, Katherine Esposito
Publikováno v:
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-5 (2020)
Abstract The coronavirus disease 2019 (COVID-19) has been declared as pandemic by the World Health Organization and is causing substantial morbidity and mortality all over the world. Type 2 diabetes, hypertension, and cardiovascular disease significa
Externí odkaz:
https://doaj.org/article/6978eb0aab954086ac35541512dc13c0